FT819 progress for lupus nephritis, RECLAIM-LN plans & Russell 3000 removal risks. Click here to read more about FATE.
In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have ...
For neurodivergent clients, their lack of follow through is often misinterpreted as avoidance. This often leads to poor experiences in therapy for this population.
Artificial intelligence is increasingly being used in mental health care, from chatbots offering guided conversations to apps ...
NeOnc Technologies Holdings (NASDAQ: NTHI) remains an early-stage biotechnology company, but the recent Abu Dhabi IND authorization for NEO212 highlights a development strategy that has become ...
Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...
People use general-purpose AI (GPAI) for mental health advice. There are better ways to do this, by using purpose-built AI.
Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...
UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease gene therapy before conducting a new study, a dramatic reversal that shows the ...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance ...
Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results